Prestige Consumer Healthcare
PBH
#4293
Rank
HK$19.77 B
Marketcap
HK$411.32
Share price
-9.02%
Change (1 day)
-38.53%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): HK$29.71

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$29.86. In 2024 the company made an earnings per share (EPS) of HK$33.70 an increase over its 2023 EPS that were of -HK$12.62.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$29.71-11.84%
2024HK$33.70-367.08%
2023-HK$12.62-138.33%
2022HK$32.9211.7%
2021HK$29.4713.6%
2020HK$25.94-651.67%
2019-HK$4.70-148.78%
2018HK$9.64-83.29%
2017HK$57.68437.23%
2016HK$10.74-34.13%
2015HK$16.3052.94%
2014HK$10.66-8.11%
2013HK$11.60
2011HK$6.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.30 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$54.16 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.43 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.66-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.39-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$48.20 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$11.05-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.53-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$232.15-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.56-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel